Amgen diagnostics interface makes it easy to digest most current publicly released information about Amgen as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.
About 88.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.76. Amgen last dividend was issued on 2018-05-16. This company had 2:1 split on 1999-11-22. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people. For more info on AMGEN please contact Robert Bradway at 805-447-1000 or go to http://www.amgen.com.
Amgen has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 88.0% of the company shares are held by institutions such as insurance companies
The company currently falls under 'Mega-Cap' category with current market capitalization of 116.32 B.
The company has Profit Margin (PM) of 9.67 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 54.26 % which suggests for every 100 dollars of sales it generated a net operating income of 0.54.
Amgen has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.59 % meaning that it created $9.59 on every $100 dollars invested by stockholders.
Amgen shows Mean Deviation of 1.01 and Risk Adjusted Performance of 0.01. Amgen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Amgen which can be compared to its rivals. Please confirm AmgenTreynor Ratio, and the relationship between Standard Deviation and Downside Variance to decide if Amgen is priced correctly providing market reflects its regular price of 176.3 per share. Given that Amgen has Jensen Alpha of 0.0, we suggest you validate Amgen prevailing market performance to make sure the company can sustain itself at future point.
Amgen Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amgen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amgen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.